Cargando…

Untargeted metabolomics analysis assisted by signal selection for comprehensively identifying metabolites of new psychoactive substances: 4-MeO-α-PVP as an example

New psychoactive substances (NPS) have been rapidly emerged as legal alternatives to controlled drugs, which raised severe public health issue. The detection and monitoring of its intake by complete metabolic profiling is an urgent and vital task. Untargeted metabolomics approach has been applied fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Hsin-Yi, Chen, Yuan-Chih, Hsu, Jing-Fang, Lu, Hsiang-Ting, Pan, Yu-Yi, Ma, Mi-Chia, Liao, Pao-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Food and Drug Administration 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208664/ https://www.ncbi.nlm.nih.gov/pubmed/37224557 http://dx.doi.org/10.38212/2224-6614.3447

Ejemplares similares

New Psychoactive Substance 5-MeO-MiPT In vivo Acute Toxicity and Hystotoxicological Study
por: Altuncı, Yusuf Ali, et al.
Publicado: (2021)

Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats
por: Noworyta-Sokołowska, Karolina, et al.
Publicado: (2016)

New psychoactive substance α-PVP in a traffic accident case
por: Rojek, Sebastian, et al.
Publicado: (2016)

New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MS(n)” and “LC-(High Resolution)-MS/MS”
por: Michely, Julian A., et al.
Publicado: (2017)

A narrative synthesis of research with 5-MeO-DMT
por: Ermakova, Anna O, et al.
Publicado: (2021)

Discovering Hair Biomarkers of Alzheimer’s Disease Using High Resolution Mass Spectrometry-Based Untargeted Metabolomics
por: Su, Yu-Hsiang, et al.
Publicado: (2023)

Structure of the {U(13)} polyoxo cluster U(13)O(8)Cl( x )(MeO)(38–x ) (x = 2.3, MeO = methoxide)
por: Fichter, Sebastian, et al.
Publicado: (2021)

Behavioral Effects of 4-CMC and 4-MeO-PVP in DBA/2J Mice After Acute and Intermittent Administration and Following Withdrawal from Intermittent 14-Day Treatment
por: Wojcieszak, Jakub, et al.
Publicado: (2021)

Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use
por: Sherwood, Alexander M., et al.
Publicado: (2020)

Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substances
por: Manier, Sascha K., et al.
Publicado: (2019)

Comparative Untargeted Metabolomics Analysis of the Psychostimulants 3,4-Methylenedioxy-Methamphetamine (MDMA), Amphetamine, and the Novel Psychoactive Substance Mephedrone after Controlled Drug Administration to Humans
por: Steuer, Andrea E., et al.
Publicado: (2020)

Toxicometabolomics of the new psychoactive substances α-PBP and α-PEP studied in HepaRG cell incubates by means of untargeted metabolomics revealed unexpected amino acid adducts
por: Manier, Sascha K., et al.
Publicado: (2020)

Determination of 3-MeO-PCP in human blood and urine in a fatal intoxication case, with a specific focus on metabolites identification
por: Arbouche, Nadia, et al.
Publicado: (2021)

Intoxication with 3-MeO-PCP alone: A case report and literature review
por: Berar, Antoine, et al.
Publicado: (2019)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Stability of Wheat Floret Metabolites during Untargeted Metabolomics Studies
por: Whitney, Kristin, et al.
Publicado: (2022)

Metabolite discovery through global annotation of untargeted metabolomics data
por: Chen, Li, et al.
Publicado: (2021)

Identification of Canine Pyometra-Associated Metabolites Using Untargeted Metabolomics
por: Zheng, Hui-Hua, et al.
Publicado: (2022)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT
por: Dakic, Vanja, et al.
Publicado: (2017)

5-MeO-DALT: the freebase of N,N-diallyl-5-methoxytryptamine
por: Chadeayne, Andrew R., et al.
Publicado: (2020)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics
por: Shen, Xiaotao, et al.
Publicado: (2019)

JUMPm: A Tool for Large-Scale Identification of Metabolites in Untargeted Metabolomics
por: Wang, Xusheng, et al.
Publicado: (2020)

Untargeted metabolomic profiling of Sphagnum fallax reveals novel antimicrobial metabolites
por: Fudyma, Jane D., et al.
Publicado: (2019)

Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study
por: Trifonova, Oxana P., et al.
Publicado: (2022)

Editorial: Targeted and untargeted metabolomics for the evaluation of plant metabolites in response to the environment
por: Han, Wenyan, et al.
Publicado: (2023)

Creation of a Plant Metabolite Spectral Library for Untargeted and Targeted Metabolomics
por: Li, Yangyang, et al.
Publicado: (2023)

Untargeted metabolomic analysis of metabolites related to body dysmorphic disorder (BDD)
por: Wang, Yawen, et al.
Publicado: (2023)

Untargeted metabolomics reveal rhizosphere metabolites mechanisms on continuous ramie cropping
por: Fu, Yafen, et al.
Publicado: (2023)

New psychoactive substances of natural origin: A brief review
por: Feng, Ling-Yi, et al.
Publicado: (2017)

Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats
por: Noworyta-Sokołowska, Karolina, et al.
Publicado: (2018)

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study
por: Barsuglia, Joseph, et al.
Publicado: (2018)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan
por: Yeh, Hsin-Tzu, et al.
Publicado: (2022)

Psychoactive substances and the political ecology of mental distress
por: Aggarwal, Sunil K, et al.
Publicado: (2012)

PSYCHOACTIVE SUBSTANCE USE AMONG MEDICAL STUDENTS
por: Ali, R.V. Zulfikar, et al.
Publicado: (1994)

Banning Psychoactive Substances: A Slippery Slope
Publicado: (2015)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_aetgpbkm6uuq9jekaujcfh33ff